3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
84
Observational
3
Expanded_access
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Myeloid
1
Gastrointestinal
1
Conditions
Gastrointestinal Stromal Tumors
1
Interventions
regorafenib
3
Sunitinib
2
Ramucirumab
2
Oxaliplatin
2
Fluorouracil
2
zenocutuzumab
1
zanidatamab
1
ulixertinib
1
trifluridine tipiracil drug combination
1
sodium thiosulfate
1
selpercatinib
1
ripretinib
1
peginterferon alfa-2a
1
pegilodecakin
1
onvansertib
1
omburtamab I-131
1
guselkumab
1
futibatinib
1
derazantinib
1
balstilimab
1
avapritinib
1
Tenofovir
1
Taxes
1
Proton Pump Inhibitors
1
Paclitaxel
1
Melphalan
1
Leucovorin
1
Laparoscopy
1
Imatinib Mesylate
1
IMM-101
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Imatinib Mesylate
×
Gastrointestinal
×
Clear all
NCT01613053
2015-04-24
MACS2226
Novartis
No longer available